---
title: "STROEHMANN DIANE — Ownership Dossier"
canonical: https://whiteintel.dev/entity/5fa7a856-8a44-549f-8141-73eaa01a3bcf
json: https://whiteintel.dev/api/public/dossier/5fa7a856-8a44-549f-8141-73eaa01a3bcf
identifier: sec:0001711461
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# STROEHMANN DIANE

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001711461`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/5fa7a856-8a44-549f-8141-73eaa01a3bcf  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/5fa7a856-8a44-549f-8141-73eaa01a3bcf  

## Ownership & control

### Holdings / subsidiaries

- **SIENNA BIOPHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/2cc09a09-3a86-57e9-9b4f-48050eddee2d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **STROEHMANN DIANE**. Human view: https://whiteintel.dev/entity/5fa7a856-8a44-549f-8141-73eaa01a3bcf · Structured JSON: https://whiteintel.dev/api/public/dossier/5fa7a856-8a44-549f-8141-73eaa01a3bcf._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._